在帕金森病中通过综合模型和数据驱动的方法进行自动化肩带刚度评估
Fatemeh Khosrobeygi1, Zahra Abouhadi2, Ailar Mahdizadeh3
1School of Kinesiology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Sensors (Basel, Switzerland)
|October 16, 2025
概括
这项研究引入了一种新的基于传感器的方法,用于客观地测量帕金森病 (PD) 中的肩部刚性. 该框架提高了诊断准确性,并为远程患者监测提供了可扩展的解决方案.
科学领域:
- 生物医学工程 生物医学工程
- 神经科学是一个神经科学.
- 可穿戴技术可穿戴技术
背景情况:
- 帕金森病 (PD) 的诊断依赖于主观的运动评估,特别是刚性.
- 目前用于量化刚度的方法缺乏客观性,并且可能会受到评分器变化的影响.
- 需要客观,可扩展和可靠的方法来评估PD相关的刚性.
研究的目的:
- 开发和验证一种新的混合框架,用于客观量化帕金森病中肩带刚性的研究.
- 从可穿戴传感器数据中整合基于模型的生物机械和数据驱动的统计特征.
- 通过使用弱监督来提高刚性评估的准确性和可解释性.
主要方法:
- 在修改的摆形测试中利用可穿戴传感器数据.
- 提取模型驱动的生物力学特征 (缓冲比率,衰变率) 和数据驱动的统计特征 (最大细节系数).
- 采用弱监管来统一特征,并从有限的数据中生成强大的标签.
主要成果:
- 与单独基于数据的方法相比,帕金森病/健康对照分类准确度提高了10% (0.71比0.64).
- 混合框架与模型驱动方法 (0.70精度) 的性能相匹配.
- 确定了硬度的取决于速度的方面,挑战了传统的临床特征,并证明了与UPDRS硬度得分的强相关性 (r = 0.78,p < 0.001).
结论:
- 拟议的混合框架提供了客观,可解释和可扩展的帕金森病中肩部刚性的评估.
- 这种基于传感器的神经技术通过远程监控功能来推进PD诊断和管理.
- 已识别的生物机械生物标志物对早期诊断和远程医疗应用具有显著的临床实用性.
相关概念视频
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
Alterations in Muscle Tone lll
29
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
29


